Ralph Benedict
Overview
Explore the profile of Ralph Benedict including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
779
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gillies J, Olson L, Almukhtar R, Strohmeier A, Szigeti K, Schretlen D, et al.
J Clin Transl Sci
. 2023 Jul;
7(1):e138.
PMID: 37396809
[This corrects the article DOI: 10.1017/cts.2023.283.].
2.
Sumowski J, Benedict R, Enzinger C, Filippi M, Geurts J, Hamalainen P, et al.
Neurology
. 2018 Jan;
90(6):278-288.
PMID: 29343470
Cognitive decline is recognized as a prevalent and debilitating symptom of multiple sclerosis (MS), especially deficits in episodic memory and processing speed. The field aims to (1) incorporate cognitive assessment...
3.
LaRocca N, Hudson L, Rudick R, Amtmann D, Balcer L, Benedict R, et al.
Mult Scler
. 2017 Aug;
24(11):1469-1484.
PMID: 28799444
Background: The Multiple Sclerosis Outcome Assessments Consortium (MSOAC) was formed by the National MS Society to develop improved measures of multiple sclerosis (MS)-related disability. Objectives: (1) To assess the current...
4.
Balcer L, Raynowska J, Nolan R, Galetta S, Kapoor R, Benedict R, et al.
Mult Scler
. 2017 Feb;
23(5):734-747.
PMID: 28206829
Low-contrast letter acuity (LCLA) has emerged as the leading outcome measure to assess visual disability in multiple sclerosis (MS) research. As visual dysfunction is one of the most common manifestations...
5.
Motl R, Cohen J, Benedict R, Phillips G, LaRocca N, Hudson L, et al.
Mult Scler
. 2017 Feb;
23(5):704-710.
PMID: 28206828
The Multiple Sclerosis Outcome Assessments Consortium (MSOAC) includes representatives from advocacy organizations, Food and Drug Administration (FDA), European Medicines Agency (EMA), National Institute of Neurological Disorders and Stroke (NINDS), academic...
6.
Feys P, Lamers I, Francis G, Benedict R, Phillips G, LaRocca N, et al.
Mult Scler
. 2017 Feb;
23(5):711-720.
PMID: 28206826
Impaired manual dexterity is a frequently reported disability in people with multiple sclerosis (MS) and is increasingly prevalent with worsening disease. While various tests and patient-reported outcome measures are available,...
7.
Hagemeier J, Woodward M, Rafique U, Amrutkar C, Bergsland N, Dwyer M, et al.
Psychiatry Res Neuroimaging
. 2016 Aug;
255:87-93.
PMID: 27567325
Even in early stages, Alzheimer's disease (AD) is associated with olfactory deficit. We assess the association of volumetric differences in subcortical deep gray matter (DGM) structures and odor identification deficit...
8.
Schwartz C, Dwyer M, Benedict R, Weinstock-Guttman B, Bergsland N, Li J, et al.
BMC Neurol
. 2016 Jul;
16:108.
PMID: 27430316
Background: To examine whether past and current reserve-related activities make the brain less susceptible to MS pathology (i.e., lesions or disease-related atrophy). Methods: This secondary analysis of a cohort study...
9.
Reserve-building activities in multiple sclerosis patients and healthy controls: a descriptive study
Schwartz C, Ayandeh A, Ramanathan M, Benedict R, Dwyer M, Weinstock-Guttman B, et al.
BMC Neurol
. 2015 Aug;
15:135.
PMID: 26264858
Background: Cognitive reserve has been implicated as a possible protective factor in multiple sclerosis (MS) but to date no study has compared reserve-building activities across disease course or to healthy...
10.
Julian L, Serafin D, Charvet L, Ackerson J, Benedict R, Braaten E, et al.
J Child Neurol
. 2012 Nov;
28(1):102-7.
PMID: 23155206
In the largest sample studied to date, we measured cognitive functioning in children and adolescents with pediatric multiple sclerosis (n = 187) as well as those with clinically isolated syndrome...